Ken Furudate

1.4k total citations
31 papers, 313 citations indexed

About

Ken Furudate is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ken Furudate has authored 31 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Ken Furudate's work include Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ken Furudate is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ken Furudate collaborates with scholars based in Japan, United States and Israel. Ken Furudate's co-authors include Wataru Kobayashi, Kosei Kubota, Koichi Takahashi, Farhad Ravandi, Marina Konopleva, Nicholas J. Short, Hagop M. Kantarjian, Musa Yılmaz, Tapan M. Kadia and Koji Sasaki and has published in prestigious journals such as Blood, Cancer and Biochemical and Biophysical Research Communications.

In The Last Decade

Ken Furudate

27 papers receiving 309 citations

Peers

Countries citing papers authored by Ken Furudate

Since Specialization

Citations

This map shows the geographic impact of Ken Furudate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Furudate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Furudate more than expected).

Fields of papers citing papers by Ken Furudate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Furudate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Furudate. The network helps show where Ken Furudate may publish in the future.

Co-authorship network of co-authors of Ken Furudate

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Furudate. A scholar is included among the top collaborators of Ken Furudate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Furudate. Ken Furudate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CLL cell-derived exosomes alter the immune and hematopoietic systems 2025 ·Leukemia ·(unknown), David Harris, (unknown), Maria Teresa Sabrina Bertilaccio, George A. Călin, Koichi Takahashi, Ping Li, Zhiming Liu, Taghi Manshouri, (unknown), Ken Furudate, Muharrem Müftüoğlu, Anwar Hossain, William G. Wierda, Michael J. Keating, Zeev Estrov	0
2	Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab 2025 ·Journal of Hematology & Oncology ·Nicholas J. Short, Hagop Kantarjian, Ken Furudate, Nitin Jain, Farhad Ravandi, (unknown), Sanam Loghavi, Lewis Nasr, Fadi Haddad, Jayastu Senapati, Rebecca Garris, Koichi Takahashi, Elias Jabbour	2
3	Spatial colocalization and molecular crosstalk of myofibroblastic CAFs and tumor cells shape lymph node metastasis in oral squamous cell carcinoma 2025 ·PLoS Genetics ·Ken Furudate, (unknown), Tadashi Yoshizawa, Yuya Sasaki, Kohei Fujikura, Shintaro Goto, (unknown), (unknown), (unknown), Hiroshi Kijima, Kosei Kubota, Ken Itoh, Wataru Kobayashi, Koichi Takahashi	1
4	Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity 2024 ·Leukemia ·Matthew Schwede, Katharina Jahn, Jack Kuipers, Linde A. Miles, Robert L. Bowman, Troy M. Robinson, Ken Furudate, Hidetaka Uryu, Tomoyuki Tanaka, Yuya Sasaki, Asiri Ediriwickrema, (unknown), Andrew J. Gentles, Ross L. Levine, Niko Beerenwinkel, Koichi Takahashi, Ravindra Majeti	10
5	Blinatumomab and Ponatinib for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updated Results and Predictors of Relapse 2024 ·Blood ·Nicholas J. Short, Hagop Kantarjian, Nitin B. Jain, Koichi Takahashi, Ken Furudate, Jayastu Senapati, Fadi Haddad, (unknown), Tapan M. Kadia, Kelly S. Chien, Koji Sasaki, (unknown), Rebecca Garris, Farhad Ravandi, Elias Jabbour	4
6	CLL Cell-Derived Exosomes Impair Immune Function and Normal Hematopoiesis in CLL 2023 ·Blood ·(unknown), David Harris, Uri Rozovski, Ping Li, Zhiming Liu, Taghi Manshouri, Maria Teresa Sabrina Bertilaccio, George A. Călin, (unknown), Koichi Takahashi, Ken Furudate, Muharrem Müftüoğlu, Anwar Hossain, Alessandra Ferrajoli, Jan A. Burger, Nitin Jain, William G. Wierda, Srđan Verstovšek, Michael J. Keating, Zeev Estrov	1
7	Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib 2022 ·Leukemia ·Yuya Sasaki, Hagop M. Kantarjian, Nicholas J. Short, Feng Wang, Ken Furudate, Hidetaka Uryu, Rebecca Garris, Nitin Jain, Koji Sasaki, Farhad Ravandi, Marina Konopleva, Guillermo Garcia‐Manero, Latasha Little, Curtis Gumbs, Li Zhao, P. Andrew Futreal, Koichi Takahashi, Elias Jabbour	17
8	Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment 2022 ·BMC Cancer ·Kosei Kubota, (unknown), (unknown), Yusuke Tanaka, Ken Furudate, (unknown), (unknown), (unknown), Wataru Kobayashi	45
9	Outcomes of TP53‐mutant acute myeloid leukemia with decitabine and venetoclax 2021 ·Cancer ·Kunhwa Kim, Abhishek Maiti, Sanam Loghavi, Rasoul Pourebrahim, Tapan M. Kadia, Caitlin R. Rausch, Ken Furudate, Naval Daver, Yesid Alvarado, Maro Ohanian, Koji Sasaki, Nicholas J. Short, Koichi Takahashi, Musa Yılmaz, Guilin Tang, Farhad Ravandi, Hagop M. Kantarjian, Courtney D. DiNardo, Marina Konopleva	100
10	Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia 2021 ·British Journal of Haematology ·Sanam Loghavi, Courtney D. DiNardo, Ken Furudate, Koichi Takahashi, Tomoyuki Tanaka, Nicholas J. Short, Tapan M. Kadia, Marina Konopleva, Rashmi Kanagal‐Shamanna, Noushin Farnoud, Sherry Pierce, Joseph D. Khoury, Jeffrey L. Jorgensen, Keyur P. Patel, Naval Daver, Musa Yılmaz, L. Jeffrey Medeiros, Hagop M. Kantarjian, Farhad Ravandi, Sa A. Wang	26
11	Mutational Landscape of MDS Patients with HMA Failure Revealed By the Correlative Analysis from Inspire Trial 2021 ·Blood ·Koichi Takahashi, Anna Jonášová, Selina M. Luger, Aref Al‐Kali, David Valcárcel, Erica D. Warlick, María Díez‐Campelo, Michael Keng, Feng Wang, Ken Furudate, (unknown), (unknown), Steven Fruchtman, Guillermo Garcia‐Manero	1
12	Clonal Hematopoiesis and Its Implications for Flow Cytometric Assessment of Measurable Residual Disease in Patients with NPM1-mutated Acute Myeloid Leukemia 2020 ·Blood ·Sanam Loghavi, Courtney D. DiNardo, Koichi Takahashi, Rashmi Kanagal‐Shamanna, Tomoyuki Tanaka, Ken Furudate, Nicholas J. Short, Tapan M. Kadia, Marina Konopleva, Noushin Farnoud, Sherry Pierce, Joseph D. Khoury, Jeffrey L. Jorgensen, Keyur P. Patel, L. Jeffrey Medeiros, Hagop M. Kantarjian, Farhad Ravandi, Sa A. Wang	1
13	Falls Due to Loss of Consciousness are Associated With Maxillofacial Fracture Severity 2019 ·Journal of Oral and Maxillofacial Surgery ·(unknown), Kosei Kubota, (unknown), Ken Furudate, Yusuke Tanaka, Wataru Kobayashi	7
14	Methotrexate-Related Lymphoproliferative Disorder in Patients With Osteonecrosis of the Jaw: A 3-Case Report and Literature Review 2017 ·Journal of Oral and Maxillofacial Surgery ·Ken Furudate, (unknown), (unknown), Wataru Kobayashi	12
15	A case of essential thrombocythemia with postextraction hemorrhage 2017 ·Japanese Journal of Oral & Maxillofacial Surgery ·(unknown), (unknown), Kosei Kubota, (unknown), Ken Furudate, Wataru Kobayashi	1
16	Localized AL amyloidosis of the tongue: A case report and literature review 2016 ·Journal of Oral and Maxillofacial Surgery Medicine and Pathology ·Kosei Kubota, (unknown), Ken Furudate, (unknown), Hiroshi Nakagawa, Wataru Kobayashi	3
17	Retinoic acid-inducible gene-I-like receptor (RLR)-mediated antiviral innate immune responses in the lower respiratory tract: Roles of TRAF3 and TRAF5 2015 ·Biochemical and Biophysical Research Communications ·(unknown), Tomoh Matsumiya, (unknown), Ryo Hayakari, Ken Furudate, Fei Xing, Hidemi Yoshida, Kunikazu Tanji, Hiroki Mizukami, Tadaatsu Imaizumi, Etsuro Ito	4
18	Professional oral health care reduces oral mucositis pain in patients treated by superselective intra-arterial chemotherapy concurrent with radiotherapy for oral cancer 2015 ·Supportive Care in Cancer ·Kosei Kubota, Wataru Kobayashi, Hirotaka Sakaki, Hiroshi Nakagawa, (unknown), (unknown), (unknown), Ken Furudate, Hiroto Kimura	33
19	Desferrioxamine, an iron chelator, inhibits CXCL10 expression induced by polyinosinic–polycytidylic acid in U373MG human astrocytoma cells 2015 ·Neuroscience Research ·Tadaatsu Imaizumi, (unknown), (unknown), Hidemi Yoshida, Ryo Hayakari, Fei Xing, Liang Wang, Tomoh Matsumiya, Kunikazu Tanji, (unknown), Ken Furudate, Shogo Kawaguchi, Manabu Murakami, Hiroshi Tanaka	12
20	Sjögren's syndrome with marked swelling of major salivary glands related to localized AL amyloidosis: A case report and literature review 2014 ·Journal of Oral and Maxillofacial Surgery Medicine and Pathology ·Kosei Kubota, Ken Furudate, Hiroshi Nakagawa, Hirotaka Sakaki, Wataru Kobayashi, Hiroto Kimura	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact